Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178601
Status:
RECRUITING
Last Update Posted:
2023-12-21
First Post:
2023-12-12
Brief Title:
A Study of RC48-ADC Combined With CadonilimabAK104in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Shanxi Province Cancer Hospital
Organization:
Shanxi Province Cancer Hospital
Organization Data
Organization:
Shanxi Province Cancer Hospital
Class:
OTHER
Study ID:
AK104-RC48 UC 01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanxi Province Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cancer Institute and Hospital Chinese Academy of Medical Sciences | OTHER |